SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Titel:
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Auteur:
Hoffmann, Markus Kleine-Weber, Hannah Schroeder, Simon Krüger, Nadine Herrler, Tanja Erichsen, Sandra Schiergens, Tobias S. Herrler, Georg Wu, Nai-Huei Nitsche, Andreas Müller, Marcel A. Drosten, Christian Pöhlmann, Stefan